Livestock vaccine demand surges but requires specialized animal-vaccine manufacturing workflows with distinct production ...

Platform-enabled vaccine design unlocks safer, more effective solutions with outer-membrane vesicles (OMVs) emerging as ...

Pharming uses living organisms as bioreactors for cheaper, sustainable drug production, but requires navigating complex IP ...

AI tools promise to compress drug development timelines from decades to years, accelerating data analysis and testing for ...

The company continues to chip away at its promised $55 billion commitment toward domestic manufacturing.

Manual cleaning remains essential in biomanufacturing despite automation, requiring risk-assessed control strategies to prevent cross-contamination.

The milestone is being celebrated as a “huge moment” for rare disease drug development.

Explore the latest news and expert commentary by Chen Dong, brought to you by the Contributor of BioProcess International.

Explore the latest news and expert commentary by Miki Lee, brought to you by the Contributor of BioProcess International.

Successful PAT implementation should start small, with the goal of integrating data into decision-making and fostering cross-functional collaboration.

Balancing in-house expertise and external support is key for CGT innovators navigating GMP production and commercialization.

CellProthera acquires catheter technology to enhance delivery of its ProtheraCytes therapy, advancing Phase III clinical ...